Search / 2621 results found

from
to
  • Updated

(The Center Square) – Department of Homeland Security Secretary Alejandro Mayorkas testified before the House Judiciary Committee Thursday about border security measures and was met with blistering criticism from Republican lawmakers. One lead critic, who’s called for Mayorkas’ impeachment, was Chip Roy, a conservative congressman from Texas.

SAN DIEGO, Feb. 15, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical-stage targeted oncology company today announced that the U.S. Food and Drug Administration (FDA) accepted the New Drug Application (NDA) for adagrasib for the treatment of patients with non-small cell lung cancer (NSCLC) harboring the KRASG12C mutation who have received at least one prior systemic therapy. The Prescription Drug User Fee Action (PDUFA) date for adagrasib is December 14, 2022.

  • Updated

DUBLIN, Calif., Feb. 15 2022 /PRNewswire/ -- TriNet, (NYSE: TNET), a leading provider of comprehensive human resources solutions for small and medium-size businesses (SMBs) today announced the completion of its acquisition of Zenefits, a leading SaaS-based human capital management (HCM) solution purpose-built for SMBs to enable people operations, from Francisco Partners. Effective today, Zenefits is a wholly-owned subsidiary of TriNet and will be known as TriNet Zenefits.